Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Price
Data
About
CVS stock price forecast
News
Competitors
Tokenization
Crypto
FAQ
CVS Health Corporation stock logo

CVS Health Corporation

CVS·NYSE

Last updated as of 2026-02-10 23:27 EST. Stock price information is sourced from TradingView and reflects real-time market prices.

Insights
Calculator
News

CVS stock price change

On the last trading day, CVS stock closed at 77.64 USD, with a price change of 2.47% for the day.
Trade stock futures

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more

CVS key data

Previous close77.64 USD
Market cap98.56B USD
Volume4.40M
P/E ratio202.87
Dividend yield (TTM)3.51%
Dividend amount0.67 USD
Last ex-dividend dateJan 22, 2026
Last payment dateFeb 02, 2026
EPS diluted (TTM)0.38 USD
Net income (FY)4.61B USD
Revenue (FY)372.69B USD
Next report dateFeb 11, 2026
EPS estimate1.000 USD
Revenue estimate-
Shares float1.27B
Beta (1Y)0.45
Tokenized stocks

Have you heard of tokenized stocks?

A new way to trade stocks — anytime, anywhere, 24/7.

Learn more

CVS Health Corporation overview

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Sector
Retail trade
Industry
Drugstore Chains
CEO
J. David Joyner
Headquarters
Woonsocket
Website
cvshealth.com
Founded
1963
Employees (FY)
300K
Change (1Y)
0
Revenue / Employee (1Y)
1.24M USD
Net income / Employee (1Y)
15.38K USD

CVS Pulse

Daily updates on CVS stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• CVS Stock Price 24h change: -3.29%. From 78.35 USD to 75.77 USD (as of Feb 9, 2026). The decline was largely driven by market caution ahead of the Feb 10 earnings release and concerns over updated Medicare Advantage payment rates impacting 2026 guidance.
• From a technical perspective, CVS has entered a consolidation phase following a volatile period. The stock is currently trading within its 52-week range of 54.06 to 85.15, with immediate support near 72.00. While long-term recovery remains the narrative, short-term momentum is neutral-to-bearish as the market digests the recent pullback and awaits confirmation of margin improvements in the insurance segment.
• CVS Health reported Q4 2025 earnings of $1.09 per share, beating the $1.00 consensus, with revenue rising 8.2% to $105.7 billion. Despite the beat, the stock saw pre-market pressure on Feb 10 as the company trimmed its 2026 operating cash flow outlook to $9 billion from $10 billion.
• CVS confirmed its 2026 adjusted EPS guidance of $7.00–$7.20, suggesting a conservative turnaround path as medical costs remain elevated and pharmacy reimbursement pressures persist.
• The Centers for Medicare & Medicaid Services (CMS) proposed a net average payment increase of only 0.09% for 2027, marking the third year of flat benchmarks that fail to keep pace with rising medical costs, pressuring managed care margins.
• The U.S. Department of Labor proposed a new rule to increase transparency regarding fees collected by Pharmacy Benefit Managers (PBMs), a move aimed at lowering drug prices that could impact business practices for major healthcare players like CVS and UnitedHealth.
See more
about 12h ago
• CVS Stock Price 24h change: -3.30%. From 78.37 USD to 75.78 USD. The decline is largely driven by investor caution ahead of the Q4 earnings report scheduled for February 10, combined with ongoing sector-wide pressure from flat 2027 Medicare Advantage rate proposals.
• From a technical perspective, the stock is showing a "short-term bearish, long-term neutral" trend. While the 200-day moving average (approx. $75.65) provides a potential support floor, the 14-day RSI has dipped toward 38-43 (Sell/Neutral), and recent price action remains below the 50-day moving average ($78.62), indicating weak momentum.
• CVS Health announced it will lay off 313 employees at its Aetna facility in Hartford as part of a broader "operational efficiency" initiative to counter rising medical costs and utilization.
• CVS Pharmacy has officially begun accepting TrumpRx discount cards across its 9,000 retail locations, aimed at providing immediate drug cost savings for eligible cash-paying patients.
• Analysts have set a cautious tone for the upcoming February 10 earnings call, with an EPS estimate of $0.99, as the market looks for updated 2026 guidance following recent regulatory shifts in PBM transparency.
• The Centers for Medicare & Medicaid Services (CMS) proposed a net average payment increase of just 0.09% for 2027, the third year of effectively flat benchmarks, significantly pressuring margins for major health insurers.
• Takeda Pharmaceutical signed a $1.7 billion AI drug discovery deal with Iambic Therapeutics, reflecting a continuing trend of major healthcare players investing heavily in AI to accelerate clinical pipelines and reduce R&D costs.
See more
about 1D ago

CVS stock price forecast

According to technical indicators for CVS stock, the price is likely to fluctuate within the range of 74.31–98.40 USD over the next week. Market analysts predict that the price of CVS stock will likely fluctuate within the range of 63.51–108.34 USD over the next months.

Based on 1-year price forecasts from 82 analysts, the highest estimate is 171.43 USD, while the lowest estimate is 65.05 USD.

For more information, please see the CVS stock price forecast Stock Price Forecast page.

Latest CVS stock news

Why Alignment Healthcare (ALHC) Shares Are Declining Today

101 finance2026-01-27 20:30:34

Why The Pennant Group (PNTG) Stock Is Dropping Sharply Today

101 finance2026-01-27 20:30:34

Should You Consider Purchasing These Two Dividend Stocks During a Market Dip?

101 finance2026-01-30 22:27:06

Exclusive-Cigna settles FTC insulin case, commits to overhauling drug pricing

101 finance2026-02-04 16:42:32

What’s Ahead in the Markets This Week: January Employment Figures, Updates on Inflation and Retail Sales; Earnings Releases from Cisco, Coca-Cola, and McDonald’s

101 finance2026-02-08 11:09:11

Dow 50,000 milestone puts focus on inflation figures and postponed January employment data: Key events to monitor this week

101 finance2026-02-08 12:42:39

CVS Health (CVS) Q4 Results: Anticipated Outcomes

101 finance2026-02-09 03:12:35

5 Key Facts to Be Aware of Before the Stock Market Starts

101 finance2026-02-09 14:39:18

Why Shares of Arthur J. Gallagher (AJG) Are Down Today

101 finance2026-02-09 23:12:35

CVS Health beats quarterly profit expectations on pharmacy performance

101 finance2026-02-10 11:45:27

CVS Health: Fourth Quarter Earnings Overview

101 finance2026-02-10 11:48:30

CVS Health pharmacy business performs strongly, quarterly profit exceeds expectations

新浪财经2026-02-10 11:53:11

CVS Sees Increases in Profit and Revenue Amid Ongoing Health Insurance Industry Upheaval

101 finance2026-02-10 13:15:29

CVS's full-year results show the turnaround in action

101 finance2026-02-10 14:51:30

US Equities Grind Higher: Dow Advances While S&P 500, Nasdaq Tread Lightly

CryptoNewsNet2026-02-10 17:39:13

With just a Bitget account, you can trade stocks and cryptocurrencies at the same time.

Join now!

FAQ

What is the stock price of CVS Health Corporation?

CVS is currently priced at 77.64 USD — its price has changed by 2.47% over the past 24 hours. You can track the stock price performance of CVS Health Corporation more closely on the price chart at the top of this page.

What is the stock ticker of CVS Health Corporation?

Depending on the exchange, the stock ticker may vary. For instance, on NYSE, CVS Health Corporation is traded under the ticker CVS.

What is the stock forecast of CVS?

We've gathered analysts' opinions on CVS Health Corporation's future price. According to their forecasts, CVS has a maximum estimate of 776.40 USD and a minimum estimate of 155.28 USD.

What is the market cap of CVS Health Corporation?

CVS Health Corporation has a market capitalization of 98.56B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Risk warning:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official Fee overview or Announcement Center page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
CVS